Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2012 1
2014 3
2015 2
2016 1
2017 5
2018 6
2019 2
2020 4
2021 2
2022 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Chimeric Antigen Receptor Therapy: How Are We Driving in Solid Tumors?
Greenbaum U, Yalniz FF, Srour SA, Rezvani K, Singh H, Olson A, Blumenschein G Jr, Hong DS, Shpall EJ, Kebriaei P. Greenbaum U, et al. Among authors: yalniz ff. Biol Blood Marrow Transplant. 2020 Oct;26(10):1759-1769. doi: 10.1016/j.bbmt.2020.06.020. Epub 2020 Jul 2. Biol Blood Marrow Transplant. 2020. PMID: 32623078 Free article. Review.
Third-line treatment with second-generation tyrosine kinase inhibitors (dasatinib or nilotinib) in patients with chronic myeloid leukemia after two prior TKIs: real-life data on a single center experience along with the review of the literature.
Ongoren S, Eskazan AE, Suzan V, Savci S, Erdogan Ozunal I, Berk S, Yalniz FF, Elverdi T, Salihoglu A, Erbilgin Y, Iseri SA, Ar MC, Baslar Z, Aydin Y, Tuzuner N, Ozbek U, Soysal T. Ongoren S, et al. Among authors: yalniz ff. Hematology. 2018 May;23(4):212-220. doi: 10.1080/10245332.2017.1385193. Epub 2017 Oct 9. Hematology. 2018. PMID: 28990873 Review.
Characteristics and Outcomes of Patients With Multiple Myeloma Who Developed Therapy-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome After Autologous Cell Transplantation.
Yalniz FF, Greenbaum U, Pasvolsky O, Milton DR, Kanagal-Shamanna R, Ramdial J, Srour S, Mehta R, Alousi A, Popat UR, Nieto Y, Kebriaei P, Al-Atrash G, Oran B, Hosing C, Ahmed S, Champlin RE, Shpall EJ, Qazilbash MH, Bashir Q. Yalniz FF, et al. Transplant Cell Ther. 2024 Feb;30(2):205.e1-205.e12. doi: 10.1016/j.jtct.2023.06.015. Epub 2023 Jul 10. Transplant Cell Ther. 2024. PMID: 37437764
Copy-number variations in adult patients with chronic immune thrombocytopenia.
Yucesan E, Hatirnaz Ng O, Yalniz FF, Yilmaz H, Salihoglu A, Sudutan T, Eskazan AE, Ongoren S, Baslar Z, Soysal T, Ozbek U, Sayitoglu M, Ar MC. Yucesan E, et al. Among authors: yalniz ff. Expert Rev Hematol. 2020 Nov;13(11):1277-1287. doi: 10.1080/17474086.2020.1819786. Epub 2020 Sep 23. Expert Rev Hematol. 2020. PMID: 32885695
CRP and ferritin in addition to the EASIX score predict CAR-T-related toxicity.
Greenbaum U, Strati P, Saliba RM, Torres J, Rondon G, Nieto Y, Hosing C, Srour SA, Westin J, Fayad LE, Lee HJ, Iyer SP, Nair R, Nastoupil LJ, Parmar S, Rodriguez MA, Samaniego F, Steiner RE, Wang M, Pinnix CC, Flowers CR, Tummala S, Ramdial JL, Yalniz FF, Hawkins M, Rezvani K, Champlin RE, Shpall EJ, Neelapu SS, Kebriaei P, Ahmed S. Greenbaum U, et al. Among authors: yalniz ff. Blood Adv. 2021 Jul 27;5(14):2799-2806. doi: 10.1182/bloodadvances.2021004575. Blood Adv. 2021. PMID: 34264268 Free PMC article.
A Pilot Trial of Lirilumab With or Without Azacitidine for Patients With Myelodysplastic Syndrome.
Yalniz FF, Daver N, Rezvani K, Kornblau S, Ohanian M, Borthakur G, DiNardo CD, Konopleva M, Burger J, Gasior Y, Pierce S, Kantarjian H, Garcia-Manero G. Yalniz FF, et al. Clin Lymphoma Myeloma Leuk. 2018 Oct;18(10):658-663.e2. doi: 10.1016/j.clml.2018.06.011. Epub 2018 Jun 15. Clin Lymphoma Myeloma Leuk. 2018. PMID: 30001986 Free PMC article. Clinical Trial.
Blast phase chronic myelomonocytic leukemia: Mayo-MDACC collaborative study of 171 cases.
Patnaik MM, Pierola AA, Vallapureddy R, Yalniz FF, Kadia TM, Jabbour EJ, Lasho T, Hanson CA, Ketterling RP, Kantarjian HM, Tefferi A, Garcia-Manero G. Patnaik MM, et al. Among authors: yalniz ff. Leukemia. 2018 Nov;32(11):2512-2518. doi: 10.1038/s41375-018-0143-8. Epub 2018 Apr 25. Leukemia. 2018. PMID: 29749401 Free PMC article. No abstract available.
Cytogenetic profile of adult AML patients in Turkey: a single center study with comprehensive comparison with literature.
Cirakoglu A, Kuru RD, Yilmaz S, Deviren A, Ongoren S, Yalniz FF, Keskin D, Eskazan AE, Salihoglu A, Cem Ar M, Sahin S, Aydin Y, Hacihanefioglu S, Baslar Z, Soysal T, Arguden YT. Cirakoglu A, et al. Among authors: yalniz ff. Afr Health Sci. 2022 Sep;22(3):183-191. doi: 10.4314/ahs.v22i3.21. Afr Health Sci. 2022. PMID: 36910358 Free PMC article.
25 results